Standard Glass IPO also known as Standard Glass Lining Technology took its offer for Initial Public Offer and the bidding starts from 6th Jan 2025 and continues till 8th Jan 2025. The price range for the bidding is from ₹133 (Min) to ₹140 (Max). The total issue is for ₹410Cr. The lot size (Minimum number of shares any have to purchase) is 107 shares, which makes the minimum investment ₹14,980/- (by taking bidding price ₹140*107 = ₹14,980).
This minimum price will attract many retail investors. The allocation for the share was on 9th Jan 2025, and the share and credit of the share were on 10th Jan 2025. The face value per share is ₹10 and the stock will list on both NSE and BSE stock exchanges. The fresh Issue is ₹210 Cr and the offer for shale is ₹200Cr. There is not any discount for both employees and retail investors. The current promoter’s holding is 72.49% and after the IPO the promoter’s holdings become 60.68%. In this, I will discuss in detail Standard Glass IPO, its latest GMP trends, valuation, company overview, and many more.
Standard Glass IPO GMP Trends
| Date | GMP Price | Trend | Kostak | Subject to Sauda |
|---|---|---|---|---|
| 06 -Jan 2025 | ₹97 | – | – | 7900 |
| 05 -Jan 2025 | ₹97 | 📈 | – | 7900 |
| 04 -Jan 2025 | ₹88 | 📈 | – | 7200 |
| 03 -Jan 2025 | ₹86 | 📈 | – | 7000 |
| 02-Jan 2025 | ₹81 | 📉 | – | 6600 |
| 01-Jan 2025 | ₹83 | 📈 | – | 6700 |
| 31-Dec 2024 | – | – | – | – |
Standard Glass Overview
Standard Glass Lining Technology deals in specialized engineering equipment. It claims to make the top five specialized manufacturers of engineering equipment that are used in the chemical and pharmaceutical sectors. Their capability is that they will provide end-to-end solutions for pharmaceutical and chemical sectors which includes design, engineering, manufacture, assembly, installation, commissioning, and establishing SOPs (Standard operating processes).
Standard Glass Lining Technology was incorporated in Sep 2012, based in Hyderabad, Telangana. They have a total of eight manufacturing units where they manufacture and assemble a wide range of products. They have orders or have business from big pharmaceutical companies such as Laurus Labs, Cadila Pharmaceuticals, and Aurobindo Pharma
Standard Glass IPO Objective
- The main objective is to use IPO funds for capital expenditure for the machinery and its types of equipment, which will be around 5% of total issue funds(₹ 10Cr). Because the fresh issue is of size ₹210Cr.
- The second objective is for the repayment of loans and borrowing and also utilize funds for investments in the company subsidiaries, which combine around ₹130Cr(62%) of total issue funds.
- The last objective is the investment in its subsidiary for the requirement of capital expenditure and will acquire the new company for organic growth which together combines up to ₹50Cr (25%).
Standard Glass IPO Details
| Stock Symbol | STANGLASS |
| Industry | Pharmaceutical |
| Issue Size | ₹410 Cr |
| Lot Size | 107 |
| Price Range | ₹133 – ₹140 |
| Bid Start Date | 6 Jan 2025 |
| Bid End Date | 8 Jan 2025 |
| Allotment Date | 9 Jan 2025 |
| Refund and Share Credit Date | 10 Jan 2025 |
| Listing Date | 13 Jan 2025 |
| Mandate End Date | 23 Jan 2025 |
| Lock-in end Date | 9 Apr 2025 |
| Prospectus | Download |
| Address | 10th Floor, PNR High Nest, Hydernagar, KPHB Colony, Hyderabad, Telangana – 500085, India |
| Email Id | corporate@standardglr.com |
| Phone No | +040 3518 2204 |
Standard Glass Valuation
All the valuations are in crores(Cr) INR. If you want to see more detail on the IPO then follow my blog here.
| Year | Total Assets | Revenue | Profit |
|---|---|---|---|
| 2022 March | 298 | 241 | 25 |
| 2023 March | 347 | 500 | 53 |
| 2024 March | 665 | 549 | 60 |